From 2016 to 2018, Dr. Prasad allegedly pre-signed prescriptions for controlled substances, including oxycodone, for patients he didn’t personally examine.
The prescriptions Dr. Prasad signed without examining patients to determine medical necessity cost Medicaid about $1.1 million and cost Medicare nearly $594,000.
Dr. Prasad also allegedly pre-signed prescriptions for controlled substances while he was travelling abroad. Two nurse practitioners and the owner of the clinic where he worked are listed as co-conspirators in the indictment, but they’re all unnamed.
Authorities said Dr. Prasad was aware that some patients paid for the unnecessary prescriptions using their Medicare Part D and Medicaid benefits.
More articles on anesthesia:
4 hierarchical chronic condition codes added in 2019
Former pain practice CEO found guilty of 8 counts in $4M kickback operation — 4 details
Arkansas won’t expand CRNA scope of practice — 3 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.